Cargando…
Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin
OBJECTIVE: A major site of action for the atheroprotective drug nicotinic acid (NA) is adipose tissue, via the G-protein-coupled receptor, GPR109A. Since, adipose tissue is an active secretory organ that contributes both positively and negatively to systemic inflammatory processes associated with ca...
Autores principales: | Digby, Janet E., McNeill, Eileen, Dyar, Oliver J., Lam, Vincent, Greaves, David R., Choudhury, Robin P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839075/ https://www.ncbi.nlm.nih.gov/pubmed/19781706 http://dx.doi.org/10.1016/j.atherosclerosis.2009.08.045 |
Ejemplares similares
-
Fractalkine Promotes Human Monocyte Survival via a Reduction in Oxidative Stress
por: White, Gemma E., et al.
Publicado: (2014) -
MCP-1 and RANTES Polymorphisms in Korean Diabetic End-Stage Renal Disease
por: Joo, Kwon Wook, et al.
Publicado: (2007) -
Stimulation of Alpha7 Nicotinic Acetylcholine Receptor Attenuates Nicotine-Induced Upregulation of MMP, MCP-1, and RANTES through Modulating ERK1/2/AP-1 Signaling Pathway in RAW264.7 and MOVAS Cells
por: Liu, Liping, et al.
Publicado: (2017) -
Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer
por: Sáenz-López, Pablo, et al.
Publicado: (2008) -
Resveratrol treatment reduces expression of MCP‐1, IL‐6, IL‐8 and RANTES in endometriotic stromal cells
por: Kolahdouz‐Mohammadi, Roya, et al.
Publicado: (2020)